Patent ID: 7749714

Claim:
A method of diagnosing presence of prostate cancer in a subject, the method comprising: (a) obtaining a serum or plasma sample from a male subject; (b) determining a level of anti MCP-1 antibodies in said serum or plasma sample obtained from the subject; (c) comparing said level of anti MCP-1 antibodies in said serum or plasma sample with a level of anti-MCP-1 antibodies in serum or plasma samples from a population of normal healthy male controls, wherein an increase in anti MCP-1 antibody level in said sample of said subject as compared to levels from said normal healthy male controls indicates the presence of prostate cancer in the subject; (d) wherein when said comparing in (c) indicates increased anti MCP-1 antibody levels in said sample of said subject, as compared to levels from said normal healthy male controls, subjecting said subject having increased anti-MCP-1 antibody levels to a further diagnostic method for prostate cancer; and (e) determining the presence of prostate cancer in said subject having increased anti-MCP-1 antibody levels compared to levels from said normal healthy male controls based on said increase in anti MCP-1 antibody level and said further diagnostic method.